183 related articles for article (PubMed ID: 16790747)
21. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.
Glomski IJ; Piris-Gimenez A; Huerre M; Mock M; Goossens PL
PLoS Pathog; 2007 Jun; 3(6):e76. PubMed ID: 17542645
[TBL] [Abstract][Full Text] [Related]
22. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
[TBL] [Abstract][Full Text] [Related]
23. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
[TBL] [Abstract][Full Text] [Related]
24. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax.
Drysdale M; Heninger S; Hutt J; Chen Y; Lyons CR; Koehler TM
EMBO J; 2005 Jan; 24(1):221-7. PubMed ID: 15616593
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
Xu Q; Hesek ED; Zeng M
Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
[TBL] [Abstract][Full Text] [Related]
26. Bacillus anthracis-derived nitric oxide induces protein S-nitrosylation contributing to macrophage death.
Chung MC; Narayanan A; Popova TG; Kashanchi F; Bailey CL; Popov SG
Biochem Biophys Res Commun; 2013 Jan; 430(1):125-30. PubMed ID: 23178574
[TBL] [Abstract][Full Text] [Related]
27. Treatment of experimental anthrax with recombinant capsule depolymerase.
Scorpio A; Tobery SA; Ribot WJ; Friedlander AM
Antimicrob Agents Chemother; 2008 Mar; 52(3):1014-20. PubMed ID: 18160516
[TBL] [Abstract][Full Text] [Related]
28. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
[TBL] [Abstract][Full Text] [Related]
29. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
[TBL] [Abstract][Full Text] [Related]
30. ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis.
McGillivray SM; Ebrahimi CM; Fisher N; Sabet M; Zhang DX; Chen Y; Haste NM; Aroian RV; Gallo RL; Guiney DG; Friedlander AM; Koehler TM; Nizet V
J Innate Immun; 2009; 1(5):494-506. PubMed ID: 20375606
[TBL] [Abstract][Full Text] [Related]
31. Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.
Jeon JH; Kim YH; Choi MK; Kim KA; Lee HR; Jang J; Kim YR; Chun JH; Eo SK; Kim TS; Rhie GE
BMC Microbiol; 2014 Dec; 14():300. PubMed ID: 25472474
[TBL] [Abstract][Full Text] [Related]
32. The stringent response of Bacillus anthracis contributes to sporulation but not to virulence.
van Schaik W; Prigent J; Fouet A
Microbiology (Reading); 2007 Dec; 153(Pt 12):4234-4239. PubMed ID: 18048936
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein biosynthesis by prolipoprotein diacylglyceryl transferase is required for efficient spore germination and full virulence of Bacillus anthracis.
Okugawa S; Moayeri M; Pomerantsev AP; Sastalla I; Crown D; Gupta PK; Leppla SH
Mol Microbiol; 2012 Jan; 83(1):96-109. PubMed ID: 22103323
[TBL] [Abstract][Full Text] [Related]
34. Activation of the latent PlcR regulon in Bacillus anthracis.
Sastalla I; Maltese LM; Pomerantseva OM; Pomerantsev AP; Keane-Myers A; Leppla SH
Microbiology (Reading); 2010 Oct; 156(Pt 10):2982-2993. PubMed ID: 20688829
[TBL] [Abstract][Full Text] [Related]
35. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.
Heninger S; Drysdale M; Lovchik J; Hutt J; Lipscomb MF; Koehler TM; Lyons CR
Infect Immun; 2006 Nov; 74(11):6067-74. PubMed ID: 16923785
[TBL] [Abstract][Full Text] [Related]
36. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.
Bozue JA; Parthasarathy N; Phillips LR; Cote CK; Fellows PF; Mendelson I; Shafferman A; Friedlander AM
Microb Pathog; 2005 Jan; 38(1):1-12. PubMed ID: 15652290
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a Bacillus anthracis spore coat-surface protein that influences coat-surface morphology.
Mallozzi M; Bozue J; Giorno R; Moody KS; Slack A; Cote C; Qiu D; Wang R; McKenney P; Lai EM; Maddock JR; Friedlander A; Welkos S; Eichenberger P; Driks A
FEMS Microbiol Lett; 2008 Dec; 289(1):110-7. PubMed ID: 19054101
[TBL] [Abstract][Full Text] [Related]
38. Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections.
McKevitt MT; Bryant KM; Shakir SM; Larabee JL; Blanke SR; Lovchik J; Lyons CR; Ballard JD
Infect Immun; 2007 Dec; 75(12):5726-34. PubMed ID: 17923523
[TBL] [Abstract][Full Text] [Related]
39. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
40. [The effect of heterologous bacilli on the infectious process in anthrax in an experiment].
Bulantsev AL; Lipnitskiĭ AV
Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):24-6. PubMed ID: 10925867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
